Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. (2018)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kex395
PubMed Identifier: 29216396
Publication URI: http://europepmc.org/abstract/MED/29216396
Type: Journal Article/Review
Volume: 57
Parent Publication: Rheumatology (Oxford, England)
Issue: 3
ISSN: 1462-0324